Phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with heavily pretreated triple-negative metastatic breast cancer

被引：0
|
作者：
Modi, Shanu
Pusztai, Lajos
Forero, Andres
Mita, Monica
Miller, Kathy D.
Weise, Amy
Krop, Ian
Burris, Howard, III
Kalinsky, Kevin
Tsai, Michaela
Liu, Minetta C.
Hurvitz, Sara A.
Wilks, Sharon
Ademuyiwa, Foluso
Diab, Sami
Han, Hyo S.
Kato, Giraldo
Nanda, Rita
O'Shaughnessy, Joyce
Kostic, Ana
Li, Martha
Specht, Jennifer
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[5] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[6] Karmanos Canc Inst, Detroit, MI USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[9] Columbia Univ, Med Ctr, New York, NY USA
[10] Allina Hlth, Virginia Piper Canc Inst, Minneapolis, MN USA
[11] Mayo Clin, Rochester, MN USA
[12] Univ Calif Los Angeles, Los Angeles, CA USA
[13] Texas Oncol, San Antonio, TX USA
[14] Washington Univ, St Louis, MO USA
[15] US Oncol Denver, Denver, CO USA
[16] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[17] Virginia G Piper Canc Care Network, Scottsdale, AZ USA
[18] Univ Chicago, Chicago, IL 60637 USA
[19] Baylor Univ, Med Ctr, Waco, TX 76798 USA
[20] US Oncol, Texas Oncol, Dallas, TX USA
[21] Seattle Genet Inc, Bothell, WA USA
[22] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD3-14
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1 study of the antibody-drug conjugate (ADC) SGN-LIV1A in patients with heavily pretreated metastatic breast cancer
    Forero-Torres, A.
    Modi, S.
    Specht, J.
    Miller, K.
    Weise, A.
    Burris, H., III
    Liu, M.
    Krop, I.
    Pusztai, L.
    Kostic, A.
    Li, M.
    Mita, M.
    CANCER RESEARCH, 2017, 77
  • [2] Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with metastatic breast cancer
    Forero, A.
    Burris, H., III
    Mita, M.
    Specht, J.
    Weise, A.
    Liu, M. C.
    Modi, S.
    Pusztai, L.
    Kostic, A.
    Yang, J.
    Li, M.
    Hengel, S.
    Miller, K.
    CANCER RESEARCH, 2016, 76
  • [3] SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer
    Sussman, Django
    Smith, Leia M.
    Anderson, Martha E.
    Duniho, Steve
    Hunter, Joshua H.
    Kostner, Heather
    Miyamoto, Jamie B.
    Nesterova, Albina
    Westendorf, Lori
    Van Epps, Heather A.
    Whiting, Nancy
    Benjamin, Dennis R.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2991 - 3000
  • [4] SGN-LIV1A, an antibody-drug conjugate (ADC), in patients with LIV-1-positive breast cancer.
    Kostic, Ana
    Anderson, Martha
    Duniho, Steven
    Miyamoto, Jamie
    Nesterova, Albina
    Sussman, Django
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] SGN-LIV1A: A phase 1 trial evaluating a novel antibody-drug conjugate in patients with LIV-1-positive breast cancer
    Forero, Andres
    Burris, Howard, III
    LoRusso, Patricia
    Specht, Jennifer
    Miller, Kathy
    Mita, Monica
    Liu, Minetta C.
    Modi, Shanu
    Pusztai, Lajos
    Sussman, Django
    Kostic, Ana
    CANCER RESEARCH, 2015, 75
  • [6] SGN-LIV1A: a development stage antibody drug-conjugate targeting LIV-1 for the treatment of metastatic breast cancer.
    Sussman, Django
    Smith, Leia M.
    Anderson, Martha E.
    Duniho, Steve
    Hunter, Joshua H.
    Kostner, Heather
    Miyamoto, Jamie B.
    Nesterova, Albina
    Westendorf, Lori
    Van Epps, Heather A.
    Whiting, Nancy
    Benjamin, Dennis R.
    CANCER RESEARCH, 2013, 73 (08)
  • [7] Preclinical combinations of the antibody-drug conjugate SGN-LIV1A with chemotherapies show increased activity
    Li, Fu
    Anderson, Martha
    Hunter, Joshua
    Miyamoto, Jaime
    Ulrich, Michelle
    Kostic, Ana
    Law, Che-Leung
    Sussman, Django
    CANCER RESEARCH, 2016, 76
  • [8] Sacituzumab govitecan: a new antibody-drug conjugate for metastatic triple-negative breast cancer
    Banys-Paluchowski, M.
    Krawczyk, Natalia
    ONKOLOGE, 2021, 27 (03): : 287 - 290
  • [9] Development of CDCP1-targeting antibody-drug conjugate for Triple negative and metastatic breast cancer
    Gough, Madeline
    Khan, Tashbib
    Kwah, Kayden
    He, Yaowu
    Ratnayake, Gishan
    Pyke, Christopher
    Snell, Cameron
    Hooper, John
    Kryza, Thomas
    CANCER RESEARCH, 2023, 83 (05)
  • [10] New Biomarkers in a Novel Antibody-Drug Conjugate for Triple-Negative Breast Cancer
    Nagayama, Aiko
    ONCOLOGIST, 2018, 23 : S5 - S5
12345